Ig apheresis for the treatment of severe DCM patients

Atherosclerosis Supplements

Volumn 14, Issue 1, 2013, Pages 213-218

  Pokrovsky, Sergey N ^a   Ezhov, Marat V ^a   Safarova, Maya S ^a   Saidova, Marina A ^a   Shitov, Viktor N ^a   Afanasieva, Marina I ^a   Khaustov, Andrew I ^b   Adamova, Irina Yu ^a   Afanasieva, Olga I ^a   Konovalov, Gennady A ^b  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b MEDSI Clinic   (Russian Federation)

Author keywords

Cardiodepressive autoantibodies; Dilated cardiomyopathy; Heart failure; Ig apheresis; Immunoadsorption

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AUTOANTIBODY; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN; SPIRONOLACTONE;

ADULT; APHERESIS; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; MALE; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; THERAPY EFFECT;

ABSORPTION; ADULT; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; BLOOD COMPONENT REMOVAL; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOSORBENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECEPTORS, ADRENERGIC, BETA-1; RECOVERY OF FUNCTION; RUSSIA; STROKE VOLUME; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84872858852     PISSN: 15675688     EISSN: 18785050     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2012.10.028     Document Type: Article

References (23)

1. Maron B., Towbin J., Thiene G., et al. Contemporary definition and classification of the cardiomyopathies: an American heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006, 113:1807-1816.
2. Taylor D., Edwards L., Boucek M., et al. Registry of the international society for heart and lung transplantation: twenty-third official adult heart transplantation report. J Heart Lung Transplant 2006, 25:869-879.
3. Caforio A., Grazzini M., Mann J., et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992, 85:1734-1742.
4. Limas C., Goldenberg I., Limas C. Autoantibodies against beta-adrenoreceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989, 64:97-103.
5. Magnusson Y., Wallukat G., Waastein F., et al. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoreceptor with positive chronotropic effect. Circulation 1994, 89:2760-2767.
6. Fu L., Magnusson Y., Bergh C., et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993, 91:1964-1968.
7. Magnusson Y., Marullo S., Hoyer S., et al. Mapping of a functional autoimmune epitope on the β1 adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1990, 86:1658-1663.
8. Wallukat G., Wollenberger A., Morwinski R., Pitschner H. Anti-beta1-adrenoreceptor antibodies with chronotropic activity from serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 1995, 27:397-406.
9. Jane-wit D., Altuntas C., Johnson J., et al. β1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation 2007, 116:399-410.
10. Wallukat G., Reinke P., Dorffel W., et al. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int J Cardiol 1996, 54:191-195.
11. Kiseleva E., Afanasieva O., Kosheleva N., Pokrovsky S. Synthesis and characteristics of immunosorbent for immunoglobulins apheresis. Jpn J Apher 1997, 16:246-247.
12. Staudt A., Schaper F., Stangl V., et al. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 2001, 103:2681-2686.
13. Staudt A., Hummel A., Ruppert J., et al. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 2006, 152:712.e1-712.e6.
14. Ikeda U., Kasai H., Izawa A., et al. Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure. Curr Cardiol Rev 2008, 4:219-222.
15. Baba A., Akaishi M., Shimada M., et al. Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsoption in patients with severe heart failure. Circ J 2010, 74:1372-1378.
16. Pokrovskij S, Afanaseva O, Levashov P, et al. Synthetic antigen ability to bind beta1-adrenoreceptor autoantibodies. Patent RU 2356576 (C1) 2009-05-27.
17. Muller J., Wallukat G., Dandel M., et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000, 4:385-391.
18. Nagatomo Y., Baba A., Ito H., et al. Specific immunoadsorption therapy using tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy. J Clin Apher 2011, 26:1-8.
19. Mobidi R., Staudt A., Felix S., et al. Hemodynamic improvement and removal of autoantibodies against beta1 adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 2003, 20:345-350.
20. Lappé J.M., Pelfrey C.M., Tang W.H. Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J Card Fail 2008, 14(6):521-530.
21. Felix S., Staudt A., Landsberger M., et al. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 2002, 39:646-652.
22. Trimpert Ch, Herda L., Eckerle L., et al. Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies. Eur J Clin Invest 2010, 40:685-691.
23. Hessel F., Wegner C., Muller J., Glaveris C., Wasem J. Economic evaluation and survival analysis of immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Eur J Health Econ 2004, 5(1):58-63.